Soleil Securities Group called last weeks investor sell-off of Penwest Pharmaceuticals (Nasdaq: PPCO) "WAY overdone" and maintains a Buy ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE